It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The gastric microbiota in Crohn’s disease (CD) has not been studied. The purpose of the study was to evaluate differences of stomach microbiota between CD patients and controls. DNA was extracted from gastric mucosal and fluid samples, from 24 CD patients and 19 controls. 16S rRNA gene sequencing identified 1511 operational taxonomic units (OTUs), of which 239 passed the low abundance and low variance filters. All but one CD patients were HP negative. Fifteen bacterial phyla were identified in at least one mucosal or fluid site. Of these, Bacteroidota and Firmicutes accounted for 70% of all phyla. Proteobacteria, Actinobacteriota, and Fusobacteriota combined accounted for 27%. There was significant difference in the relative abundance of Bacteroidota, Proteobacteria, Fusobacteriota, and Campilobacterota between CD patients and controls only in gastric corpus samples. In gastric liquid, there was a significant difference only in Actinobacteriota. Pairwise comparison identified 67 differentially abundant OTUs in at least one site. Of these, 13 were present in more than one comparison, and four differentiating OTUs (Neisseriaceae, Neisseria, Absconditabacteriales, and Microbacteriaceae) were identified at all tested sites. The results reveal significant changes in gastric microbial profiles (beta diversity, phylum, and individual taxa levels) between H. pylori-negative CD patients and controls.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Maria Skłodowska-Curie National Research Institute of Oncology, Department of Genetics, Warsaw, Poland (GRID:grid.418165.f) (ISNI:0000 0004 0540 2543); Centre of Postgraduate Medical Education, Department of Gastroenterology, Hepatology and Clinical Oncology, Warsaw, Poland (GRID:grid.414852.e) (ISNI:0000 0001 2205 7719)
2 Pomeranian Medical University in Szczecin, Department of Gastroenterology, Szczecin, Poland (GRID:grid.107950.a) (ISNI:0000 0001 1411 4349)
3 Centre of Postgraduate Medical Education, Department of Gastroenterology, Hepatology and Clinical Oncology, Warsaw, Poland (GRID:grid.414852.e) (ISNI:0000 0001 2205 7719)
4 Maria Skłodowska-Curie National Research Institute of Oncology, Department of Genetics, Warsaw, Poland (GRID:grid.418165.f) (ISNI:0000 0004 0540 2543)
5 Pomeranian Medical University in Szczecin, Department of Pathology, Szczecin, Poland (GRID:grid.107950.a) (ISNI:0000 0001 1411 4349)